Functional dyspepsia is the most common reason for patients to experience chronic
epigastric pain or discomfort. The causes of functional dyspepsia are multifactorial but …

The discovery of Helicobacter pylori three decades ago is a modern medical success story. It
markedly changed our understanding of the pathophysiology of gastroduodenal diseases …

Purpose Proton pump inhibitor (PPI) drugs are approved for the management of gastric acid–
related diseases, mainly treatment of gastroesophageal reflux disease, treatment of …

Abstract M edline, P ub M ed and the Cochrane databases were searched on epidemiology
and diagnosis of H elicobacter pylori for the period of A pril 2011–M arch 2012. Several …

Helicobacter pylori (H. pylori) infection remains to be the major cause of important upper
gastrointestinal diseases such as chronic gastritis, peptic ulcer, gastric adenocarcinoma …

AIM: To evaluate whether Helicobacter pylori (H. pylori) eradication therapy benefits patients
with functional dyspepsia (FD). METHODS: Randomized controlled trials (RCTs) …

Objective To evaluate the efficacy and tolerability of replacing tetracycline with amoxicillin in
bismuth quadruple therapy. Design Subjects who were infected with Helicobacter pylori and …

Helicobacter pylori is a causative factor of various gastrointestinal tract diseases. As clinical
antibiotic-based therapy for H. pylori infection might induce bacterial drug resistance, the in …

In dieser Leitlinie sind eingetragene Warenzeichen (geschützte Warennamen) nicht
besonders kenntlich gemacht. Es kann also aus dem Fehlen eines entsprechenden …

Background Helicobacter pylori is a recognized cause of stomach cancer, but only a fraction
of infected subjects develop cancer. This systematic review 1, summarizes the prevalence of …